Study reveals hidden cancer risk in smokeless tobacco

NCT ID NCT03998735

Ongoing Knowledge-focused Sponsor: Masonic Cancer Center, University of Minnesota Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates how nornicotine, a chemical found in smokeless tobacco, can be converted inside the body into NNN, a known cancer-causing substance. Researchers will give 55 adult smokeless tobacco users herbal snuff with different levels of nornicotine and measure the NNN produced. The goal is to understand this process and inform future regulations to reduce cancer risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Herbal snuff with added nornicotine
What this could lead to: If successful, this study could help regulators set limits on nornicotine in smokeless tobacco to reduce cancer risk for users.
What could go wrong: This is a small, early-phase study focused on measuring chemical changes, not on health outcomes. It may not directly lead to any new rules or products.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates